Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
10/2005
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1226107B1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and novel n-benzyl-p-phenylenediamine-derivatives
10/05/2005EP1183233B1 Bradykinin receptor antagonists
10/05/2005EP0775110B1 Arylthio compounds as antibacterial and antiviral agents
10/05/2005CN1679200A Nonaqueous electrolyte and nonaqueous-electrolyte secondary battery
10/05/2005CN1678591A New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
10/05/2005CN1678573A Diarylurea derivatives and their use as chloride channel blockers
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221524C Diphenyl ether compounds useful in therapy
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951886 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors
10/04/2005US6951874 Compounds
10/04/2005US6951862 Calcium channel blockers comprising two benzhydril moieties
10/04/2005US6951860 Such as S-(4-methoxybenzyl)-N-(2-(N',N'-dimethylamino)ethyl) thiosalicylamide; for treatment of cardiovascular disorders
10/04/2005US6951843 Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof
10/04/2005US6951574 Primary intermediates for oxidative coloration of hair
10/04/2005CA2238275C Metalloproteinase inhibitors
09/2005
09/29/2005WO2005090322A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005WO2005090318A1 Novel amination process
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005090295A2 2-phenylpropionic acid derivatives and pharmaceutical compositions containing them
09/29/2005WO2005090282A1 Androgen receptor modulator compounds and methods
09/29/2005WO2005089815A2 Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005WO2005089269A2 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
09/29/2005US20050215825 Hydroaminomethylation of an olefin, a primary or secondary amine with a catalyst of a neutral rhodium-monodentate phosphite ligand complex prepared by contacting a neutral rhodium procatalyst with a monodentate phosphite ligand; chemical intermediate for ibutilide, terfenadine, and fexofenadine
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215637 Tuberculosis treatment
09/29/2005US20050215590 Formamide derivatives for the treatment of diseases
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215563 Proteomimetic compounds and methods
09/29/2005US20050214249 Release nitric oxide under physiological conditions and are useful for treating biological disorders
09/29/2005US20050211957 Sulfur based corrosion inhibitors
09/29/2005DE102004011720A1 Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie Radio Halogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
09/29/2005CA2560790A1 Novel amination process
09/29/2005CA2559919A1 Sulphonamide derivatives
09/29/2005CA2554855A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005EP1580301A1 Sulfur based corrosion inhibitors
09/28/2005EP1580185A1 Secondary n-Alkylhydroxylated p-Phenylendiamins, dye composition for keratin fibers containing them, processes and uses.
09/28/2005EP1578737A1 Substituted heterocyclic compounds
09/28/2005EP1578414A2 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
09/28/2005EP1233955B1 Process for preparing piperazine-substituted aliphatic carboxylates
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease
09/27/2005US6949682 Unsaturated aldehydes such as 2,3-bis-(2-chlorobenzylidene)succinaldehyde, formed by dimerization and used as antimitotic, antiproliferative or antitumor agents
09/27/2005US6949655 Acyclic piperidine derivatives
09/27/2005US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors
09/27/2005US6949567 Asymmetric amidine-substituted diphenylureas; diseases treated by the inhibition of intracellular protein degradation pathways, e.g. proteases, proteasome; anticarcinogenic agents; immunological modulators
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949553 Aliphatic compounds, their synthesis method, and utilization of the same
09/27/2005US6949552 Remedial agent for anxiety neurosis or depression and piperazine derivative
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2192731C Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/26/2005CA2502255A1 Sulfur based corrosion inhibitors
09/22/2005WO2005087754A1 Substituted morpholine and thiomorpholine derivatives
09/22/2005WO2005087753A1 Reagent for reaction
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087708A1 Phenyl indan derivatives
09/22/2005WO2005087236A1 Novel m3 muscarinic acetylcholine receptor antagonists
09/22/2005WO2005087211A1 Anti-parasitic compounds and methods of their use
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209275 Beta 2-adrenergic receptor agonists
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050209223 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
09/22/2005DE102004010893A1 Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New ß-keto amide compounds with MCH-antagonistic effect and pharmaceutical compositions containing them
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/21/2005EP1577288A1 Selective estrogen receptor modulators
09/21/2005EP1575939A1 Novel compounds having selective inhibiting effect at gsk3
09/21/2005EP1575914A1 Aromatic derivatives as hiv aspartyl protease inhibitors
09/21/2005EP1575912A1 Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005EP1575575A2 Safe chemical uncouplers for the treatment of obesity
09/21/2005EP1575538A1 Novel m- phenylendiamine derivatives as coupler components for the colouring of keratin fibres
09/21/2005EP1575495A2 Compounds and methods
09/21/2005EP1278712B1 Nitroaromatic solubilizer for nitroxyls in aromatic solvents
09/21/2005EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin
09/21/2005CN1670009A Propynyl or dienyl biaromatic compounds
09/21/2005CN1219774C Non-sterioid inflammation-resisting compound
09/21/2005CN1219764C W-carboxyaryl substituted diphenyl ureas as RAF kinase inhibitors
09/21/2005CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
09/20/2005US6946579 3-carbocycle carbonyl-3-phenylpropionaldehyde intermediates and preparation by alkylating a carbocycle benzyl ketone with an allyl halide and oxidizing the product
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946532 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors
09/20/2005US6946480 Glutaminyl based DPIV inhibitors
09/20/2005US6946478 Compounds
09/20/2005US6946475 Anticancer calcium channel blockers
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946453 Such as 7-azido-6-demethyl-6-deoxy-4-dedimethylamino tetracycline; for treatment of arthritis, bone disorders (osteoporosis), and emphysema
09/20/2005CA2236588C Water soluble cross-linking agents
09/15/2005WO2005085275A1 Inhibitors of hepatitis c virus ns3 protease
09/15/2005WO2005085221A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
09/15/2005WO2005085188A2 Compounds and methods for anti-tumor therapy
09/15/2005WO2005084668A1 Medicine for prevention and/or treatment of ischemic circulatory disease
09/15/2005WO2005084658A1 Derivatives of actarit and their therapeutic use
09/15/2005WO2005049604A3 Antithrombotic aromatic ethers
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 341